Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Cardiovascular·MeSH: Churg-Strauss Syndrome
Prevalence
5.0 / 100K
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Eosinophilic Granulomatosis With Polyangiitis (EGPA)?
There are 2 clinical trials targeting Eosinophilic Granulomatosis With Polyangiitis (EGPA) tracked by BioSniper.
What is the prevalence of Eosinophilic Granulomatosis With Polyangiitis (EGPA)?
The estimated prevalence of Eosinophilic Granulomatosis With Polyangiitis (EGPA) is approximately 5.0 per 100,000 population.
Deep-dive into Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis